🇺🇸 FDA

Company profile · Sponsor

Zhejiang

Zhejiang University

CAF5D73 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Zhejiang (CAF5D73) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CAF5D73
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. Cetuximab β；Fruquintinib；

    Zhejiang

    Colorectal Neoplasms

    phase 2 small molecule active

    1 trial

  2. HRS-4642+AG+Nimotuzumab

    Zhejiang

    Borderline Resectable Pancreatic Adenocarcinoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Zhejiang?

Zhejiang (CAF5D73) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Zhejiang sponsor?

We track 2 ClinicalTrials.gov-linked programs for Zhejiang, including Cetuximab β；Fruquintinib； and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Zhejiang company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.